Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06322849 · ClinicalTrials.gov registry record · NA

Active Elements of Digital Single-session Interventions

A NA study, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
887
Enrollment target

NCT06322849: Completed NA study, sponsored by Northwestern University.

NCT06322849 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 887 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06322849, a NA study, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
887 participants
Enrollment target

Study Summary

Depression is a leading cause of disability in young adults. However, access to care is limited due to structural and psychological barriers. Single-session interventions (SSIs) are structured programs designed to maximize the therapeutic output in one interaction between the patient and the provider or a program. Project ABC, a single-session intervention (SSI), has been shown to be effective in reducing depressive symptoms. Project ABC is based on four components-psychoeducation, testimonials, saying is believing exercises, and action planning. However, it is unclear what are the effects of the individual components. The primary aim of this study is to calculate the main effects of the candidate components-psychoeducation, testimonials + saying is believing exercises, and action planning-on Patient Health Questionnaire-8 (PHQ-8) scores at 8-week follow-up. The secondary aims of this study are to: 1. calculate the main effects of the candidate components-psychoeducation, testimonials + saying is believing exercises, and action planning-on PHQ-8 scores at immediate post-treatment and 2-week follow-up. 2. calculate the interaction effects, if any, among the candidate components on PHQ-8 scores at immediate post-treatment, 2-week, and 8-week follow-up. 3. calculate the main and interaction effects of the candidate components on measures of hopelessness, autonomy, relatedness, and competence. 4. determine if the effects of the candidate components on PHQ-8 are mediated by measures of autonomy, relatedness, and competence. Additionally, the exploratory aim of this study is to determine if common factors, like credibility of the intervention and expectations to improve, can lead to symptom change.

Primary Outcome

Patient Health Questionnaire-8 is a well-validated and self-administered measure to assess depression symptom severity in the general population. Participants are asked to rate how often they are bothered by 8 items (e.g., Poor appetite or overeating) on a scale of 0 (Not at all) to 3 (Nearly every day). Total score can range from 0 to 24, with higher scores indicating higher symptom severity.

Interventions

  • BEHAVIORAL Psychoeducation
  • BEHAVIORAL Breathing exercise
  • BEHAVIORAL Testimonials and Saying is believing exercises
  • BEHAVIORAL Action planning

Trial Details

FieldValue
Enrollment Target 887 participants
Start Date 2024-05-02
Est. Completion 2024-07-18
Phase NA
Northwestern University

1,209 total trials

What the finished NCT06322849 record still lists

NCT06322849 is an interventional study that assigns participants to a tested intervention. The registered 887 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% lower).

The record links to 0 conditions, and to 4 interventions - of which Psychoeducation is the first listed.

NCT06322849 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06322849 about?

NCT06322849 is a clinical study titled "Active Elements of Digital Single-session Interventions". Depression is a leading cause of disability in young adults. However, access to care is limited due to structural and psychological barriers. Single-session interventions (SSIs) are structured programs designed to maximize the therapeutic output in one interaction between the patient and the provide...

What is the current status of trial NCT06322849?

This trial is currently completed. It is a NA study. The enrollment target is 887 participants. The study started on 2024-05-02. Estimated completion is 2024-07-18.

What interventions are being tested in trial NCT06322849?

The interventions under investigation include: Psychoeducation (BEHAVIORAL), Breathing exercise (BEHAVIORAL), Testimonials and Saying is believing exercises (BEHAVIORAL), Action planning (BEHAVIORAL).

Who is sponsoring clinical trial NCT06322849?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06322849's enrollment target sits among peer trials

887 130th of 2000 higher than 1,871 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03564340 · 890 participants · Phase 1

    Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

  • NCT05855200 · 892 participants · Phase 3

    Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

  • NCT07196748 · 882 participants · Phase 3

    A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  • NCT05174286 · 880 participants · NA

    Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06322849, the US trial registry maintained by the National Library of Medicine. NCT06322849 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.